2019 In Rheumatology: Drug Comparisons, CBD Guidelines, and more
2019 was a significant year in rheumatology. Here are the top stories covered by DocWire News this year, including drug comparisons and CBD guidelines.
2019 was a significant year in rheumatology. Here are the top stories covered by DocWire News this year, including drug comparisons and CBD guidelines.
Dr. Anne Marie Morse, about the significance and theme of this year’s World Sleep Day.
Researchers identified 23,450 trial sites; a majority of them began before 2020.
The main features of intestinal inflammation are reproduced as a biomarker for response to immune checkpoint inhibition.
An increase in intestinal permeability allows gut bacteria to reach bone marrow.
The 15-year absolute risk for completed suicide among individuals with headache was 0.21%.
This structural discovery is a step toward the development of next-generation therapies to modulate LDL.
Researchers aimed to determine whether a two-pill antihypertensive strategy is effective at controlling hypertension.
Dr. Georgia Vasilakis Tsatiris of The CardioNerds speaks to Dr. Kevin Alexander about the impact of ATTR-CM.
Researchers found two effective treatments for metaplastic breast cancer.
After one year of therapeutic intervention, less oxidation and aggregation were detected in lipoproteins.